Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Center of Excellence to advance biopharmaceutical manufacturing.
The Biomanufacturing Excellence Act of 2025 aims to establish a National Biopharmaceutical Center of Excellence to facilitate and accelerate manufacturing innovation, support good manufacturing practices, and provide for collaboration among public, private, and nonprofit institutions. The Center will focus on developing and demonstrating flexible biopharmaceutical manufacturing technologies, improving upstream and downstream processes, and supporting good manufacturing practices. It will also facilitate workforce training programs for biopharmaceutical manufacturing.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.